# A Study of KHK4827 in Subjects With Palmoplantar Pustulosis

> **NCT04061252** · PHASE3 · COMPLETED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 126 (actual)

## Conditions studied

- Palmoplantar Pustulosis

## Interventions

- **DRUG:** KHK4827
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04061252
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-10
- **Primary completion:** 2021-08-11
- **Final completion:** 2022-08-05
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2023-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04061252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04061252, "A Study of KHK4827 in Subjects With Palmoplantar Pustulosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04061252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*